IRCT20180530039917N2
Completed
Phase 4
Evaluation the therapeutic effects of intravenous Ketamine and intravenous Morphine in the treatment of patients with renal colic
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Renal Colic.
- Sponsor
- Ahvaz University of Medical Sciences
- Enrollment
- 136
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •VAS more than 5
- •Patients with renal colic due to stones (confirmed by imaging)
Exclusion Criteria
- •History of cardiovascular disease and hypertension
- •Breastfeeding
- •Drug addiction
- •History of seizure
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the therapeutic effect of intravenous flurbiprofen axetil against mesenteric traction syndrome by continuous measurement of systemic vascular resistance index using a FloTrac sensor.patients scheduled for elective open abdominal surgeryJPRN-UMIN000007802Daiyukai General Hospital Dep of Anesthesia40
Not yet recruiting
Phase 4
A clinical trial to compare the effects of two drugs, dexmedetomidine , a drug used in treatment of raised blood pressure and paracetamol , a drug used for pain relief in patients undergoing laparoscopic cholecystectomy.Health Condition 1: - Health Condition 2: O- Medical and SurgicalCTRI/2022/10/046735DrGadde Venkata Harshitha
Not yet recruiting
Not Applicable
Comparing the efficacy of intravenous and submucosal routes of Dexamethasone administration in reducing post-operative complications after lower third molar surgery.Health Condition 1: K011- Impacted teethCTRI/2021/07/034900DrThajunnisa M K
Recruiting
Phase 2
A comparative study on the efficacy of intravenous dexamethasone and lidocaine in reducing respiratory complications after general anesthesiarespiratory complications after general anesthesia.J20IRCT20160301026866N5Esfahan University of Medical Sciences90
Completed
Phase 2
Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patientsIRCT20151227025726N20Shahid Beheshti University of Medical Sciences80